Evidence map›Paper›PMID 24209747›Full record

ArticleCell reports2013

Combinatorial H3K9acS10ph histone modification in IgH locus S regions targets 14-3-3 adaptors and AID to specify antibody class-switch DNA recombination.

Guideng Li, Clayton A White, Tonika Lam, Egest J Pone, Daniel C Tran, Ken L Hayama, Hong Zan, Zhenming Xu, Paolo Casali

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Epigenetics of the antibody and autoantibody response.Current opinion in immunology · 2020
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. EScientific reports · 2017
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Guideng Li *Institute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Clayton A WhiteInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Tonika LamInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Egest J PoneInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Daniel C TranInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Ken L HayamaInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Hong ZanInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Zhenming Xu *Institute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
Paolo CasaliInstitute for Immunology and School of Medicine, University of California, Irvine, 3028 Hewitt Hall, Irvine, CA 92697-4120, USA.
University of California, Irvine · USThe University of Texas Health Science Center at San Antonio · US

Funding

Intrinsic B cell epigenetic regulation of antibody and autoantibody responses by Sirt1R01AI105813 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2014 to 2023
$4.5M
Somatic hypermutation and class switching in autoimmunityR01AI079705 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CASALI, PAOLO · 2010 to 2019
$4.1M
Immunology Research Training ProgramT32AI060573 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI PEARLMAN, ERIC · 2005 to 2020
$1.9M
Molecular mechanisms in the generation of autoantibodies and lupusR56AI079705 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2008 to 2008
$381k
Epigenetic downregulation of the antibody response and inhibition of autoimmunityR56AI105813 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI CASALI, PAOLO · 2013 to 2013
$286k
NIAID NIH HHS AI 060573NIAID NIH HHS AI 079705NIAID NIH HHS AI 105813NIAID NIH HHS R01 AI079705NIAID NIH HHS R01 AI105813NIAID NIH HHS R56 AI079705NIAID NIH HHS R56 AI105813NIAID NIH HHS T32 AI060573
6 · The paper itself

Abstract

Class-switch DNA recombination (CSR) is central to the antibody response, in that it changes the immunoglobulin heavy chain (IgH) constant region, thereby diversifying biological effector functions of antibodies. The activation-induced cytidine deaminase (AID)-centered CSR machinery excises and rejoins DNA between an upstream (donor) and a downstream (acceptor) S region, which precede the respective constant region DNA. AID is stabilized on S regions by 14-3-3 adaptors. These adaptors display a high affinity for 5'-AGCT-3' repeats, which recur in all S regions. However, how 14-3-3, AID, and the CSR machinery target exclusively the donor and acceptor S regions is poorly understood. Here, we show that histone methyltransferases and acetyltransferases are induced by CD40 or Toll-like receptor signaling and catalyze H3K4me3 and H3K9ac/K14ac histone modifications, which are enriched in S regions but do not specify the S region targets of CSR. By contrast, the combinatorial H3K9acS10ph modification specifically marks the S regions set to recombine and directly recruits 14-3-3 adaptors for AID stabilization there. Inhibition of the enzymatic activity of GCN5 and PCAF histone acetyltransferases reduces H3K9acS10ph in S regions, 14-3-3 and AID stabilization, and CSR. Thus, H3K9acS10ph is a histone code that is "written" specifically in S regions and is "read" by 14-3-3 adaptors to target AID for CSR as an important biological outcome.

Indexed as

14-3-3 ProteinsAICDA (Activation-Induced Cytidine Deaminase)AnimalsCytidine DeaminaseDNAHistonesImmunoglobulin Class SwitchingImmunoglobulin Heavy ChainsImmunoglobulin Variable RegionMiceMice, Inbred C57BLModels, MolecularRecombination, Genetic14-3-3 ProteinsAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminaseDNAHistonesImmunoglobulin Heavy ChainsImmunoglobulin Variable Region

Identifiers

PMID24209747
PMCPMC3951903
OpenAlexW2090132659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.